Investigation of the potential beneficial effects of cannabidiol in the management of oral-lingual-buccal dyskinesias using animal studies and a clinical trial
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2016
At a glance
- Drugs Cannabidiol (Primary) ; Vitamin E
- Indications Drug-induced dyskinesia
- Focus Proof of concept; Therapeutic Use
- 02 Dec 2016 Status changed from active, no longer recruiting to completed.
- 02 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 15 May 2015 New trial record